Products

EnsoSleep
EnsoData
Clinical Decision Support & Reference
EnsoSleep is an FDA-cleared, AI-powered, cloud-based solution that optimizes the sleep lab workflow by automating the scoring, viewing, editing, and reporting of Polysomnography (PSG) and Home Sleep Apnea Tests (HSATs). It helps clinicians accelerate diagnosis, improve consistency, and expand patient care.

See all 1 product →

About EnsoData

EnsoData is a healthcare AI company that develops artificial intelligence and machine learning solutions to streamline the diagnosis and treatment of sleep disorders. Their flagship product, EnsoSleep, is an FDA-cleared, AI-powered software that automates the scoring and analysis of in-lab polysomnography (PSG) and home sleep apnea tests (HSATs). This technology significantly reduces the manual review time for clinicians, allowing them to focus more on patient care and interpretation of results. EnsoData’s platform is trained on one of the world’s largest databases of sleep studies, encompassing over 3.8 million studies, which enhances the accuracy and reliability of its AI algorithms.

Beyond EnsoSleep, the company offers a comprehensive AI-driven ecosystem for sleep medicine, including EnsoHST for multi-night home sleep testing, EnsoHub for a unified platform to access and review AI-scored studies, and Therapy Track for seamless workflow across the patient journey from diagnosis to long-term care. EnsoData’s solutions aim to address the significant challenge of undiagnosed sleep apnea, which affects an estimated 54 million Americans and 936 million people globally, with approximately 80% remaining undiagnosed. By providing accessible, accurate, and efficient diagnostic tools, EnsoData seeks to expand patient access to sleep care, accelerate diagnoses, and improve overall patient outcomes.

Focus Areas

Artificial Intelligence Machine Learning Sleep Medicine Sleep Apnea Diagnosis Home Sleep Testing Remote Patient Monitoring Waveform Analysis Digital Health

Business Intelligence

TechnologyCloud-native, AI-powered waveform analysis platform (EnsoHub, EnsoSleep, EnsoHST, Therapy Track)

What Physicians Need to Know

AI-Powered Diagnostic Analysis & Scoring
EnsoData specializes in AI-powered diagnostic analysis and scoring for both in-lab polysomnography (PSG) and home sleep apnea tests (HSATs). Their FDA-cleared EnsoSleep solution automates the scoring of sleep studies, improving consistency and expediting turnaround times for patient data.
Waveform AI Technology
EnsoData's core technology is Waveform AI, which transforms physiological signals from medical devices into actionable clinical insights. This technology is trained on a vast database of over 2.8 million sleep studies, making it one of the largest waveform databases globally for clinical AI development.
Comprehensive Sleep Care Platform
EnsoData offers an AI-driven ecosystem that spans the entire sleep care journey, from diagnosis to long-term patient care. This includes EnsoHST for multi-night home sleep testing, EnsoSleep for AI-assisted scoring, EnsoHub for accessing and reviewing studies, and Therapy Track for long-term therapy monitoring.
Remote Patient Monitoring (RPM)
EnsoData provides an RPM solution within its EnsoSleep PPG AI ecosystem. This allows clinicians to continuously track sleep apnea treatment effectiveness using wearable PPG-based devices and a mobile application, enabling proactive intervention and consistent AHI monitoring across various treatment modalities.
Improving Patient Access & Affordability
EnsoData aims to expand access to sleep medicine, accelerate diagnosis, and improve outcomes, particularly for the large population suffering from undiagnosed sleep apnea. Their solutions, including affordable and reusable home sleep testing devices, make high-quality sleep analysis more accessible.
Cloud-Based Software
EnsoData's software is cloud-based, offering accessibility from anywhere at any time without requiring a VPN. This eliminates complex installations, ensures all users are on the same software version, and facilitates seamless integration and ease of use.
Interoperability
Their software is designed to be interoperable with most leading sleep diagnostic in-lab and home sleep testing devices, allowing clinics to utilize their existing equipment.
FDA Cleared
EnsoData's AI-powered solutions, including EnsoSleep and EnsoHST, are FDA cleared, providing diagnostic analysis of in-lab and home sleep studies.
Physician Tip

For physicians, EnsoData's solutions offer several key advantages. The AI-powered scoring and analysis, particularly with EnsoSleep, can significantly reduce the time spent on manual scoring, allowing sleep technologists and physicians to focus more on patient care and other clinical activities. The platform's ability to view, edit, and generate reports for all devices from one platform streamlines workflows and improves consistency in staging and scoring. EnsoData's focus on Total Sleep Time and PPG-based sleep analysis can increase confidence in HSAT results and assist in reaching undiagnosed patient populations. Furthermore, their dedicated team of clinicians, including RPSGTs, provides comprehensive onboarding, scoring QA, and peer-to-peer learning opportunities, ensuring that the software is effectively integrated into clinical workflows and that physicians and technologists receive expert guidance and support. The remote patient monitoring capabilities allow for continuous tracking of treatment effectiveness and proactive intervention, leading to improved patient outcomes. The company also collaborates with partners to simplify the handoff from physician-signed sleep reports to DME providers, expediting care for newly diagnosed sleep disorders.

EnsoData's cloud-based platform is designed for seamless integration. They offer bidirectional, real-time syncing of lab orders and results with Electronic Health Records (EHR) and practice management tools. They have established partnerships with companies like Parachute Health, Aeroflow Health, and React Health to streamline workflows and connect sleep disorder diagnosis to therapy. EnsoData also integrates with compatible FDA-cleared pulse oximetry devices, such as the Nonin WristOx2® Model 3150, for home sleep apnea testing. Integrations can be configured quickly, often in minutes for basic workflows, with hands-on implementation support available.

Products by EnsoData

1 product in the directory

EnsoSleep
EnsoData
Clinical Decision Support & Reference
EnsoSleep is an FDA-cleared, AI-powered, cloud-based solution that optimizes the sleep lab workflow by automating the scoring, viewing, editing, and reporting of Polysomnography (PSG) and Home Sleep Apnea Tests (HSATs). It helps clinicians accelerate diagnosis, improve consistency, and expand patient care.

What the Web Says

EnsoData is a healthcare technology company that utilizes artificial intelligence to streamline and enhance the analysis of sleep study data, primarily through its product EnsoSleep. Reviews indicate that the software is highly effective in automating sleep study scoring, reducing turnaround times, and improving efficiency for healthcare providers. The company is generally viewed positively for its innovative AI solutions and supportive customer service.

Overall: Positive

Strengths

  • EnsoSleep accurately scores sleep studies, often within 15 minutes.
  • The software significantly reduces turnaround time for sleep study results.
  • It helps decrease costs and improve the scalability of sleep lab operations.
  • EnsoData's customer support is highly responsive and helpful.
  • The platform is easy to use and integrates well with existing systems.
  • AI-powered scoring frees up time for clinicians to focus on patient care and program development.

Limitations

  • Some users have experienced initial difficulties with integration, particularly with EMR systems like EPIC.
  • The transfer process for data can sometimes be less seamless, partly depending on the client's HIT department.
  • The AI, while accurate, may require some manual re-scoring for certain events, such as N3 sleep stages or differentiating central vs. obstructive respiratory events in studies with artifacts.
  • The software does not currently score 'Mixed' respiratory events, requiring manual adjustment.
  • One review mentioned that new updates have made customized options less user-friendly.
  • There is a desire for the software to detect poor channels and adjust accordingly for analysis.

Based on reviews from: G2, Capterra, SimplyHired, Zippia, SourceForge, EnsoData Website, Reddit

Last updated: 2026-07-18

Videos

News, demos, and interviews about EnsoData.

Loading videos...

Videos load interactively. If none appear, search YouTube for EnsoData →

View all on YouTube

Press & Coverage

EnsoData Newsroom
EnsoData™ Raises $20M Series B to Expand Commercial Team
EnsoData announced a $20 million Series B financing round led by Questa Capital to accelerate the adoption of its AI-powered sleep medicine solutions and expand its commercial team.
2025-06
EnsoData Newsroom
Latest EnsoData FDA 510(k) Clearance Enables AI-Powered Sleep Diagnosis Using Pulse Oximetry Devices
EnsoData received FDA 510(k) clearance for technology enabling AI-powered sleep diagnosis using FDA-cleared pulse oximetry devices, expanding access to sleep disorder identification.
2024-02
EnsoData Newsroom
EnsoData Unveils New Product Offering with AI-Driven Remote Physiological Monitoring for Sleep-Disordered Breathing
EnsoData introduced Therapy Track, a new AI-driven remote physiological monitoring solution for sleep-disordered breathing, creating a streamlined pathway from diagnostic testing to therapeutic monitoring.
2025-05
EnsoData Newsroom
EnsoData Announces Collaboration with Takeda to Improve Narcolepsy Type 1 Diagnostic Journey Using AI Tools and Technology
EnsoData announced a collaboration with Takeda to develop, validate, and integrate an AI-based polysomnography (PSG) algorithm into EnsoSleep to improve the diagnostic journey for Narcolepsy Type 1.
unknown
EnsoData Newsroom
EnsoData Earns American Academy of Sleep Medicine Autoscoring Software Certification™ for EnsoSleep
EnsoData's EnsoSleep received American Academy of Sleep Medicine Autoscoring Software Certification, validating its AI-powered sleep scoring capabilities.
unknown
The Business Journals
EnsoData lands $20M to accelerate AI adoption in sleep medicine
Madison-based EnsoData raised $20 million in Series B funding to expand its AI solutions for diagnosing and monitoring sleep apnea, with Questa Capital leading the round.
2025-06
EnsoData Newsroom
Wisconsin-Based Startup Earns New FDA Clearance for Artificial Intelligence Sleep Scoring Solution
EnsoData received FDA clearance for EnsoSleep, an AI sleep scoring solution that simplifies the analysis of PSG and HSAT waveforms.
unknown
MobiHealthNews
EnsoData receives FDA clearance for sleep analysis software
EnsoData's EnsoSleep, a sleep analysis software utilizing machine learning, received FDA clearance.
unknown

Frequently Asked Questions

EnsoData's AI, EnsoSleep, automates the scoring of in-lab and home sleep studies, significantly reducing manual review time for technologists and physicians. This automation improves consistency and accuracy in diagnoses, allowing clinicians to focus more on patient care rather than tedious scoring tasks.
EnsoData offers EnsoSleep for diagnostic analysis and EnsoHST for home sleep testing, which includes Therapy Track for managing sleep therapy. Therapy Track leverages AI to help optimize therapy initiation and adherence, while also supporting remote patient monitoring capabilities to track patient progress and engagement.
EnsoData prioritizes HIPAA compliance and robust data security measures to protect patient information. Their solutions are designed for seamless integration with existing EMRs and sleep lab systems, minimizing disruption and ensuring a smooth transition for clinical staff.
By streamlining the diagnostic process and reducing the time to diagnosis, EnsoData can help increase the capacity of sleep labs, thereby improving patient access. The efficiency gains and use of cost-effective home sleep testing solutions can also lead to cost savings for providers, potentially translating to more affordable care options.
EnsoData provides comprehensive support, including dedicated implementation specialists to ensure a smooth onboarding process and ongoing technical assistance. They work closely with organizations to integrate their AI into existing workflows and provide training for clinical staff.
EnsoData has a strong track record as a leader in AI-powered sleep medicine, backed by significant investment and a growing customer base. They actively pursue partnerships with leading healthcare organizations and technology providers like React Health, Nonin, and Blackstone Medical Services to expand their reach and enhance their offerings.

Investors

Who's funded EnsoData.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

NeurixaHealthAI™ is a healthcare AI company dedicated to eliminating administrative waste in the healthcare system, which they estimate to be $1.1 trillion annually. They offer a production-ready healthcare intelligence platform designed to simplify operations, improve outcomes, and accelerate the journey from patient care to financial performance. The platform is not a collection of point solutions […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.